Navigation Links
IMA ACB Test COBAS Mira Plus, 100T

ProductsIMA ACB Test COBAS Mira Plus, 100T
Company Inverness Medical Innovations
Item IMA ACB Test COBAS Mira Plus, 100T
Features Inquire
Description The Albumin Cobalt Binding (ACB®) Test is a clinical chemistry assay that detects Ischemia Modified Albumin (IMA®) by measuring the cobalt binding capacity of albumin in a patient serum sample. First identified in the early 1990s, IMA is produced when circulating albumin comes in contact with ischemic tissue in the heart. During ischemia, the N-terminus of albumin is altered through a series of chemical reactions that cause free radical damage to albumin. This altered albumin is produced continually during ischemia. IMA concentrations in blood rise quickly and remain elevated during an ischemic event, returning to normal level several hours after cessation of ischemia. IMA can be used in conjunction with electrocardiogram (ECG) and troponin as an aid to rule out ACS at presentation-saving time, resources and money.
Info Inverness Medical Innovations
Customer Service: 800-257-9525
Web site: http://www.invernessmedical.com/

Related medicine products :

1. COBAS TaqMan Analyzer
2. Eppendorf ThermoStat Plus, without block
3. Vibratome 3000 Plus, Automated
4. Vibratome 1000 Plus, CE
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products:
(Date:11/25/2009)...were treated with cisplatin-based chemotherapy had...side effects and Raynaud-like phenomena, than men ...to a new study published online November 25 in the...arianne Brydy, M.D., of the Department of Oncology..., and colleagues conducted a cross-sectional study...
(Date:11/25/2009)...ollaboration between UCLA engineers and physicians...lion Americans who suffer from peripheral arterial...rteries, peripheral arterial disease, or PAD, is a...ries reduce blood flow to the limbs. The condition...art attack and stroke, and its progression can res...
(Date:11/25/2009)...w definite conclusions, experts say, , ,...ic patients with blocked coronary arteries, there ...r whether patients undergo bypass surgery or angio..., Bypass surgery has been the standard treatmen...se. However, less invasive approaches such as angi...
(Date:11/25/2009)...ent clinics to resume Monday, Nov. 30 , ... -- Centegra Health System is continuing to offer ... Centegra Primary Care (CPC) vaccination clinics s...clinics are at CPC sites in Huntley, Woodstock, Cr...: ,   From 4:30 to 7:30 p.m. Tuesday, ...
(Date:11/25/2009)...s, study finds , , WEDNESDAY, Nov. 25 (...mong the potential problems faced by long-term sur...cisplatin-based chemotherapy, a new study has foun...ated for unilateral testicular cancer between 1980...ucted from 1998 to 2002. , The researchers foun...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...esearchers from the University of Chicago reportin... that nine out of ten doctors believe that it is a...However, only three out of four doctors encourage ...y mentions his or her religious beliefs and experi...
...rectile dysfunction is thought to be a common prob...ing the young, college aged men. But now, Dr. Naja...spital// in Chicago, went a step further in findin...llege-age males in Chicago to throw more light on ...
...espite all the rain, there seems to be enough shin...in cancer malignant melanoma, according to the Env...has embarked on a SunWise Program enabling free ki...tors apply different sunscreen and skin lotions on...
...f breast cancer in women has occurred because of t... seek remedy from a prevalent chemotherapy medicat...ovarian and lung cancers, is getting known for its...mutations are twenty times more receptive to carbo...
...ehavioral problems are more likely to occur in chi...ance abuse, domestic violence and mental health, o...in the Archives of General Psychiatry. // Th...at can contribute to behavior problems in children...
...espite the widespread belief that residents of nur...epartments in hospitals, //it has been found that ...are needs of the residents, even in the presence o...ty of Western Australia and the Royal Perth Hospit...
Other Medicine News:Health News:Doctors' Response To Patients' Religious Beliefs Can Vary 2Health News:Doctors' Response To Patients' Religious Beliefs Can Vary 3Health News:Maternal Difficulties Increase Risk of Behavior Problems in Children 2Health News:Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds 2
(Date:11/25/2009)...e-FirstCall/--ERT(Nasdaq: ERES ),announcedtodaytha...andKeithSchneck,theCompany,sExecutiveVicePresident...ffrayHealthCareConferenceat1:30PMESTonDecember1,20...yaccessthepresentationbyvisitingtheCompany,scorpor...beaccessedat http://www.corporate-ir.net/ireye/con...
(Date:11/25/2009)...swire/--TheFDAgrantedtraditionalapprovalforINTELEN...transcriptaseinhibitor(NNRTI).INTELENCEistheonlyNN...cedadultswhoareexperiencingvirologicfailurewithHIV...ARV)agents.Thetraditionalapprovalisbasedon48-weekd...LENCEiscurrentlymarketedintheU.S.byTibotecTherapeu...
(Date:11/25/2009)...RNewswire/--AMPACFineChemicalsLLC(AFC),asubsidiary...edtodaythatitreceivedtheEnvironmentalResponsibilit...mentalSummit,sponsoredbytheCaliforniaManufacturers...nmentalAssociation(IEA)andtheChemicalIndustryCounc...estigiousawardavailablefromallthreeorganizationsan...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Targeting helpers of heat shock proteins could help treat cancer cardiovascular disease 8950 1Targeting helpers of heat shock proteins could help treat cancer cardiovascular disease 8950 2State Launches New Campaign to Help Pregnant Smokers Go Tobacco Free 49623 1State Launches New Campaign to Help Pregnant Smokers Go Tobacco Free 49623 2Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations 12728 1Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations 12728 2